Synergy Pharmaceuticals, Inc. - Warrants
SGYPW
SGYPW was delisted on the 6th of December, 2016.
5 hedge funds and large institutions have $319K invested in Synergy Pharmaceuticals, Inc. - Warrants in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
25% more funds holding
Funds holding: 4 → 5 (+1)
68% less capital invested
Capital invested by funds: $1.01M → $319K (-$694K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Twin Tree Management
Dallas,
Texas
|
+$7.91K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$486 |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$24 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$4.37K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Fidelity Investments
Boston,
Massachusetts
| $311K | – | – | – |
|
|
2
Twin Tree Management
Dallas,
Texas
| $6K | +$7.91K | +6,500 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $1K | +$24 | +20 | +3% |
|
|
U
4
UBS
Zurich,
Switzerland
| $1K | +$486 | +400 | +31% |
|
|
SM
5
Sabby Management
Miami Beach,
Florida
| $321 | -$4.37K | -3,591 | -0.9% |
|
SGYPW Hedge Fund Activity: Q3 2014 in Review
5 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) for Q3 2014, worth a combined $319K — down 68% from $1.01M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new SGYPW positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Twin Tree Management, opening a new position worth an estimated $7.91K. The largest seller was Sabby Management, cutting an estimated $4.37K.
- 5 institutional investors held Synergy Pharmaceuticals, Inc. - Warrants (SGYPW) as of Q3 2014, up from 4 in Q2 2014.
- Funds reported $319K of Synergy Pharmaceuticals, Inc. - Warrants stock for Q3 2014, down 68% quarter-over-quarter.
- 1 fund opened new Synergy Pharmaceuticals, Inc. - Warrants positions in Q3 2014 and 0 closed out, a net change of +1 holder.
- The largest Synergy Pharmaceuticals, Inc. - Warrants buyer in Q3 2014 was Twin Tree Management, an estimated $7.91K added.
- The largest Synergy Pharmaceuticals, Inc. - Warrants seller in Q3 2014 was Sabby Management, an estimated $4.37K sold.
Based on aggregated 13F filings for Q3 2014.